PAMED COVID-19 Resource Center
As the COVID-19 pandemic continues to change our lives and the way you practice each day, PAMED is committed to providing our membership with only the most pertinent and timely updates through this site. Thank you for your commitment to your patients and your membership.
PAMED COVID-19 Briefing:
May 17, 2022
FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years
The FDA has amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine. Read more.
PAMED is updating the Briefing section of our
COVID-19 page. This is where we’ll put the top updates that have happened. If you’d like to receive an email or text when an update is available, you can sign up for either below.
Got COVID-19 Questions? Let us Help
We know there are a lot of questions out there. PAMED members are welcome to use our online form to submit questions.